ERICA JARAMILLO: Open Payments
NPI 1518389709 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,331 in 67 payments from 17 companies in 2025. Trend: 2023 $1,278 · 2024 $924 · 2025 $1,331
Food & beverage: $1,331
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $325 |
| AstraZeneca Pharmaceuticals LP | 4 | $212 |
| Astellas Pharma US Inc | 5 | $93 |
| Amgen Inc. | 6 | $90 |
| PFIZER INC. | 5 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $73 |
| Novo Nordisk Inc | 4 | $71 |
| Dexcom, Inc. | 4 | $70 |
| Exact Sciences Corporation | 4 | $69 |
| Phathom Pharmaceuticals, Inc. | 4 | $58 |
Products named: QULIPTA, BREZTRI, Veozah, Kerendia, Ozempic, Dexcom G6 Transmitter, Cologuard Collection Kit, OTEZLA.
Industry payments across AR — which companies pay providers there.
